Form 4: Encompass Health Corp: CEO Mark Tarr Awarded Stock Options
SEC Form 4 Filing
Encompass Health Corp's CEO, Mark J. Tarr, received non-qualified stock options exercisable over three years starting March 1, 2025.
Summary
- Mark J. Tarr, President & CEO of Encompass Health Corp, was granted non-qualified stock options.
- The transaction date was March 1, 2024.
- The options allow Tarr to buy 41,524 shares of Encompass Health Common Stock at an exercise price of $74.2.
- The options vest in equal annual installments over a three-year period, commencing on March 1, 2025.
- Tarr directly owns these derivative securities.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a standard practice and generally viewed as a positive incentive for management.
Positives
- The granting of stock options to the CEO aligns his interests with those of the shareholders, incentivizing him to improve the company's performance.
- The vesting schedule encourages long-term commitment from the CEO.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
Stock option grants are a common form of executive compensation in the healthcare industry, aligning management incentives with shareholder value.
Comparison to Industry Standards
- Stock option grants are a typical component of executive compensation packages in publicly traded companies, including those in the healthcare sector like Select Medical Holdings Corporation and Kindred Healthcare.
- The vesting schedule of three years is also a common practice to ensure long-term commitment from executives.
- The number of shares granted and the exercise price would need to be compared to similar grants at comparable companies to assess the relative value and incentive provided.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive incentive for the CEO.
- Employees may see this as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of the stock option grant. |
| 03/01/2025 | Commencement date for the annual vesting of the stock options. |
| 03/04/2024 | Date of the form filing. |
| 03/01/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.